- Report
- April 2019
- 208 Pages
Global
From €2899EUR$2,999USD£2,492GBP
- Report
- February 2021
- 420 Pages
United States
From €2320EUR$2,400USD£1,994GBP
- Report
- March 2019
- 17 Pages
Global
€9667EUR$10,000USD£8,309GBP
- Report
- March 2019
- 25 Pages
Global
€9667EUR$10,000USD£8,309GBP
- Report
- February 2024
- 89 Pages
Global
From €3500EUR$3,878USD£3,114GBP
Cymbalta is a medication used to treat mental disorders such as depression, anxiety, and fibromyalgia. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) that works by increasing the levels of serotonin and norepinephrine in the brain. Cymbalta is one of the most commonly prescribed medications for mental disorders, and is used by millions of people around the world. It is available in both generic and brand name forms, and is available in both oral and injectable forms. Cymbalta is also used to treat chronic pain, and is often prescribed in combination with other medications.
The Cymbalta market is highly competitive, with many different companies offering their own versions of the medication. Some of the major players in the market include Eli Lilly, Pfizer, GlaxoSmithKline, and AstraZeneca. Other companies that offer Cymbalta include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more
